Herpes Genitalis Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of Herpes Simplex Virus, Type 2 (HSV-2) Therapeutic DNA Vaccine in Adults With Symptomatic Genital HSV-2 Infection
The purpose of this trial is to evaluate the safety and efficacy of a therapeutic DNA vaccine in adults with symptomatic herpes simplex virus type 2 (i.e., genital herpes).
To evaluate the safety and efficacy of 4 doses of VCL-HB01, a therapeutic HSV plasmid DNA vaccine formulated with Vaxfectin® in HSV-2-seropositive adults with a reported history of symptomatic genital herpes for at least one year. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02852876 -
Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food
|
Phase 1 | |
Completed |
NCT04664127 -
Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
|
||
Completed |
NCT00405821 -
Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda
|
Phase 2 | |
Completed |
NCT04165122 -
Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection
|
Phase 2 | |
Completed |
NCT00158483 -
Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)
|
Phase 2 | |
Terminated |
NCT00079911 -
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
|
Phase 4 | |
Active, not recruiting |
NCT04950712 -
An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
|
||
Completed |
NCT00486200 -
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
|
Phase 2 | |
Completed |
NCT00158860 -
A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.
|
Phase 4 | |
Active, not recruiting |
NCT00005663 -
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
|
Phase 3 | |
Active, not recruiting |
NCT04073082 -
Safety and Efficacy of Laser Therapy in Gynaecology
|
||
Terminated |
NCT00122525 -
Effect of Male Circumcision on HIV Incidence (ANRS 1265)
|
Phase 3 | |
Completed |
NCT00158509 -
Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding
|
Phase 2 | |
Completed |
NCT00076232 -
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
|
Phase 3 | |
Completed |
NCT00023582 -
HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru
|
N/A |